GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Johnson & Johnson Dives Into 2018 With 15 New Deals January 7, 2018 ReachBio LLC Celebrates 10 Years In Business September 11, 2017 <b>Rhodes College</b> Unveils New $34 Million Cutting-Edge Science Facility August 31, 2017
